ArticleOncotarget2017

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma.

Cynthia M Simbulan-Rosenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.